​

Tonix Pharmaceuticals (TNXP) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Tonix Pharmaceuticals Revenue Highlights

Latest Revenue (Y)

$13.11M

Latest Revenue (Q)

$6.88M

Tonix Pharmaceuticals Revenue by Period

Tonix Pharmaceuticals Revenue by Year

DateRevenueChange
2025-12-31$13.11M29.85%
2024-12-31$10.09M29.94%
2023-12-31$7.77M100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31-100.00%
2012-12-31-100.00%
2011-12-31-100.00%
2010-12-31-100.00%
2009-12-31-100.00%
2008-12-31--

Tonix Pharmaceuticals generated $13.11M in revenue during NA 2025, up 29.85% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Tonix Pharmaceuticals Revenue by Quarter

DateRevenueChange
2026-03-31$6.88M27.61%
2025-12-31$5.39M63.83%
2025-09-30$3.29M64.66%
2025-06-30$2.00M-17.74%
2025-03-31$2.43M-5.93%
2024-12-31$2.58M-8.50%
2024-09-30$2.82M27.81%
2024-06-30$2.21M-11.04%
2024-03-31$2.48M-34.32%
2023-12-31$3.78M-5.26%
2023-09-30$3.99M100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31--100.00%
2019-12-31$-500.00100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31-100.00%
2012-12-31-100.00%
2012-09-30-100.00%
2012-06-30-100.00%
2012-03-31-100.00%
2011-12-31-100.00%
2011-09-30-100.00%
2011-06-30-100.00%
2011-03-31-100.00%
2010-12-31-100.00%
2010-09-30-100.00%
2010-06-30-100.00%
2010-03-31-100.00%
2009-12-31-100.00%
2009-09-30-100.00%
2009-06-30-100.00%
2009-03-31-100.00%
2008-12-31-100.00%
2008-09-30-100.00%
2008-06-30-100.00%
2008-03-31--

Tonix Pharmaceuticals generated $6.88M in revenue during Q1 2026, up 27.61% compared to the previous quarter, and up 266.38% compared to the same period a year ago.

Tonix Pharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
IPHAInnate Pharma$51.90M$16.56M
TNXPTonix Pharmaceuticals$13.11M$6.88M
FATEFate Therapeutics$6.65M$1.30M
MISTMilestone Pharmaceuticals$1.55M$238.00K
MCRBSeres Therapeutics$789.00K$358.00K
AVTXAvalo Therapeutics$59.00K-
FBRXForte Biosciences--
ELTXElicio Therapeutics--
NKTXNkarta--
ELDNEledon Pharmaceuticals--

TNXP Revenue FAQ

What is Tonix Pharmaceuticals’s yearly revenue?

Tonix Pharmaceuticals's yearly revenue for 2025 was $13.11M, representing an increase of 29.85% compared to 2024. The company's yearly revenue for 2024 was $10.09M, representing an increase of 29.94% compared to 2023. TNXP's yearly revenue for 2023 was $7.77M, representing an increase of 100.00% compared to 2022.

What is Tonix Pharmaceuticals’s quarterly revenue?

Tonix Pharmaceuticals's quarterly revenue for Q1 2026 was $6.88M, a 27.61% increase from the previous quarter (Q4 2025), and a 183.16% increase year-over-year (Q1 2025). The company's quarterly revenue for Q4 2025 was $5.39M, a 63.83% increase from the previous quarter (Q3 2025), and a 108.75% increase year-over-year (Q4 2024). TNXP's quarterly revenue for Q3 2025 was $3.29M, a 64.66% increase from the previous quarter (Q2 2025), and a 16.58% increase year-over-year (Q3 2024).

What is Tonix Pharmaceuticals’s revenue growth rate?

Tonix Pharmaceuticals's revenue growth rate for the last 3 years (2023-2025) was 68.73%, and for the last 5 years (2021-2025) was 0%.